BillionToOne (BLLN) Metrics: History & Chart

BillionToOne, Inc.(BLLN)

Medical - Diagnostics & Research · Menlo Park, CA

$109.06+3.16 (+2.98%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About BillionToOne, Inc.

BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.

Menlo Park, CA

713 employees

www.billiontoone.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Oguzhan Atay

View full financials

Third-Party DCF Estimate (FMP)	$1337.94
Price Gap vs Third-Party Estimate	+1126.79%

7D Total Return	-10.40%
30D Total Return	+9.73%
YTD Total Return	+33.26%
1Y Total Return	N/A
3Y Total Return	N/A
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+33.26%
2025	N/A
2024	N/A
2023	N/A
2022	N/A
2021	N/A

CAGR TTM	N/A
CAGR 3Y	N/A
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	175.87
PE Ratio Avg TTM	879.32
PE Ratio Avg 3Y	879.32
Current VS TTM Avg	-80.00%
Current VS 3Y Avg	-80.00%
Current VS 5Y Avg	-80.00%

All Metrics

BLLN Valuation Metrics

BLLN Stock Price Metrics

BLLN Dividend Metrics

BLLN Growth Rate Metrics

BLLN Discounted Cash Flow Metrics

BLLN Returns By Period

BLLN Yearly Returns

BLLN Average Annual Returns By Period (CAGR)

BLLN Revenue Metrics

BLLN PE Ratio Metrics

BLLN PS Ratio Metrics

BLLN PB Ratio Metrics

BLLN Price to Free Cash Flow Ratio Metrics

BLLN Debt to Equity Ratio Metrics

BLLN PEG Ratio Metrics

BLLN FCF Yield

BLLN Earnings Yield

BLLN EBITDA Yield

BLLN OCF Yield

BLLN EV/EBIT Ratio Metrics

BLLN EV/EBITDA Ratio Metrics

BLLN EV/Assets Ratio Metrics

BLLN EV/Sales Ratio Metrics

BLLN Current Ratio Metrics

BLLN Quick Ratio Metrics

BLLN ROIC Metrics

BLLN Return on Assets Metrics

BLLN Return on Equity Metrics

BLLN Net Profit Margin Metrics

BLLN Gross Profit Margin Metrics

BLLN Tax Rate Metrics

PS Ratio	14.94
PS Ratio Avg TTM	14.66
PS Ratio Avg 3Y	14.66
Current VS TTM Avg	+1.90%
Current VS 3Y Avg	+1.90%
Current VS 5Y Avg	+1.90%

PB Ratio	11.06
PB Ratio Avg TTM	9.56
PB Ratio Avg 3Y	9.56
Current VS TTM Avg	+15.74%
Current VS 3Y Avg	+15.74%
Current VS 5Y Avg	+15.74%

PFCF Ratio	179.02
PFCF Ratio Avg TTM	194.41
PFCF Ratio Avg 3Y	194.41
Current VS TTM Avg	-7.92%
Current VS 3Y Avg	-7.92%
Current VS 5Y Avg	-7.92%

Debt/Equity Ratio	0.27
Debt/Equity Ratio Avg TTM	0.40
Debt/Equity Ratio Avg 3Y	0.33
Current VS TTM Avg	-33.38%
Current VS 3Y Avg	-18.61%
Current VS 5Y Avg	-18.61%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	0.56%
FCF Yield Avg TTM	0.53%
FCF Yield Avg 3Y	0.53%
Current VS TTM Avg	+5.62%
Current VS 3Y Avg	+5.62%
Current VS 5Y Avg	+5.62%

Earnings Yield	0.57%
Earnings Yield Avg TTM	0.37%
Earnings Yield Avg 3Y	0.37%
Current VS TTM Avg	+55.72%
Current VS 3Y Avg	+55.72%
Current VS 5Y Avg	+55.72%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	127.81
Ev/Ebit Ratio Avg TTM	157.20
Ev/Ebit Ratio Avg 3Y	157.20
Current VS TTM Avg	-18.70%
Current VS 3Y Avg	-18.70%
Current VS 5Y Avg	-18.70%

Ev/Ebitda Ratio	99.54
Ev/Ebitda Ratio Avg TTM	111.94
Ev/Ebitda Ratio Avg 3Y	111.94
Current VS TTM Avg	-11.07%
Current VS 3Y Avg	-11.07%
Current VS 5Y Avg	-11.07%

Ev/Assets Ratio	7.58
Ev/Assets Ratio Avg TTM	7.07
Ev/Assets Ratio Avg 3Y	7.07
Current VS TTM Avg	+7.23%
Current VS 3Y Avg	+7.23%
Current VS 5Y Avg	+7.23%

Ev/Sales Ratio	13.93
Ev/Sales Ratio Avg TTM	13.65
Ev/Sales Ratio Avg 3Y	13.65
Current VS TTM Avg	+2.02%
Current VS 3Y Avg	+2.02%
Current VS 5Y Avg	+2.02%

Current Ratio	11.69
Current Ratio Avg TTM	9.28
Current Ratio Avg 3Y	6.03
Current VS TTM Avg	+25.99%
Current VS 3Y Avg	+93.73%
Current VS 5Y Avg	+93.73%

Quick Ratio	11.31
Quick Ratio Avg TTM	8.91
Quick Ratio Avg 3Y	5.78
Current VS TTM Avg	+26.97%
Current VS 3Y Avg	+95.56%
Current VS 5Y Avg	+95.56%

ROIC	6.39%
ROIC Avg 3Y	(4.09%)
ROIC Avg 5Y	(4.09%)
Current VS 3Y Avg	+256.11%
Current VS 5Y Avg	+256.11%
Current VS 10Y Avg	+256.11%

ROA	4.59%
ROA Avg TTM	1.00%
ROA Avg 3Y	(0.01%)
Current VS TTM Avg	+359.51%
Current VS 3Y Avg	+56912.36%
Current VS 5Y Avg	+56912.36%

ROE	6.24%
ROE Avg TTM	(2.82%)
ROE Avg 3Y	(8.39%)
Current VS TTM Avg	+321.44%
Current VS 3Y Avg	+174.34%
Current VS 5Y Avg	+174.34%

Net Profit Margin	8.43%
Net Profit Margin Avg TTM	6.32%
Net Profit Margin Avg 3Y	(8.47%)
Current VS TTM Avg	+33.41%
Current VS 3Y Avg	+199.59%
Current VS 5Y Avg	+199.59%

Gross Profit Margin	71.27%
Gross Pft Margin Avg TTM	70.02%
Gross Pft Margin Avg 3Y	62.54%
Current VS TTM Avg	+1.79%
Current VS 3Y Avg	+13.97%
Current VS 5Y Avg	+13.97%

Tax Rate	(7.13%)
Tax Rate Avg 3Y	(0.36%)
Tax Rate Avg 5Y	(0.36%)
Current VS 3Y Avg	-1871.30%
Current VS 5Y Avg	-1871.30%
Current VS 10Y Avg	-1871.30%